Vuzix and AMA Strengthen Strategic Partnership to Address the Future of the Deskless Workforce
- Vuzix M400 smart glasses now supports the entire XpertEye assisted reality product range
- Adoption of the embedded Vivoka multilingual automatic speech recognition
ROCHESTER, NY, January 18, 2022 – Vuzix® Corporation (NASDAQ: VUZI), ("Vuzix" or, the "Company"), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, and AMA (EURONEXT GROWTH: ALAMA), a pioneer of assisted reality and workflow management software solutions, today announced the reinforcement of their partnership to grow and strengthen both organization’s ability to deliver world-class remote collaboration for the deskless workforce.
Vuzix and AMA have been closely working together for over five years and are now widening the scope of their partnership agreement to accelerate the digital transformation of their joint industrial and healthcare customer base. By proposing the lightweight and ergonomically versatile Vuzix M400 smart glasses on the entire XpertEye remote assistance product range, customers will be able to boost productivity and successfully complete remote support tasks safely and efficiently. Customers will now benefit from hands-free collaboration with voice control on XpertEye Essential as well as from seamless remote assistance with the Vuzix M400 wearable display connected to a dedicated smartphone on XpertEye Advanced.
As a strategic partner, AMA has been the first to successfully test and leverage Vivoka’s embedded multilingual automatic speech recognition, now standard on Vuzix full line of smart glasses. With 18 languages available, the XpertEye assisted reality solution embraces the unparalleled and secured voice AI capabilities of this embedded speech technology.
“Our growing relationship with AMA increasingly leverages the strong combination of a leading hardware platform and a leading software solution,” said Paul Travers, President and CEO of Vuzix. “The proven productivity improvements of our combined offering will remain a strong demand driver as industry adoption continues to accelerate this year and beyond.”
“Our partnership is taking a new step forward. We are convinced that our combined, forward looking vision of remote assistance is key to accompany the rapid digital transformation of our customers,“ said Guillaume Campion, VP Product & Partnerships at AMA.
About Vuzix Corporation
Vuzix is a leading supplier of Smart Glasses and Augmented Reality (AR) technologies and products for the consumer and enterprise markets. The Company's products include personal display and wearable computing devices that offer users a portable high-quality viewing experience, provide solutions for mobility, wearable displays and augmented reality. Vuzix holds 243 patents and patents pending and numerous IP licenses in the Video Eyewear field. The Company has won Consumer Electronics Show (or CES) awards for innovation for the years 2005 to 2022 and several wireless technology innovation awards among others. Founded in 1997, Vuzix is a public company (NASDAQ: VUZI) with offices in Rochester, NY, Oxford, UK, and Tokyo, Japan. For more information, visit the Vuzix website, Twitter and Facebook pages.
Forward-Looking Statements Disclaimer
Certain statements contained in this news release are "forward-looking statements" within the meaning of the Securities Litigation Reform Act of 1995 and applicable Canadian securities laws. Forward looking statements contained in this release relate to Vuzix Smart Glasses, our business relationship and future opportunities with and orders from AMA and its customers, and among other things the Company's leadership in the Smart Glasses and AR display industry. They are generally identified by words such as "believes," "may," "expects," "anticipates," "should" and similar expressions. Readers should not place undue reliance on such forward-looking statements, which are based upon the Company's beliefs and assumptions as of the date of this release. The Company's actual results could differ materially due to risk factors and other items described in more detail in the "Risk Factors" section of the Company's Annual Reports and MD&A filed with the United States Securities and Exchange Commission and applicable Canadian securities regulators (copies of which may be obtained at www.sedar.com or www.sec.gov). Subsequent events and developments may cause these forward-looking statements to change. The Company specifically disclaims any obligation or intention to update or revise these forward-looking statements as a result of changed events or circumstances that occur after the date of this release, except as required by applicable law.
Vuzix Media and Investor Relations Contact:
Ed McGregor, Director of Investor Relations,
Tel: (585) 359-5985
Vuzix Corporation, 25 Hendrix Road, West Henrietta, NY 14586 USA,
Investor Information – IR@vuzix.com www.vuzix.com
While most video conferencing tools quickly prove their limits outside the office, AMA’s smart workplace allows experts and frontline workers to collaborate remotely on any device via a secure software platform, perfectly tailored to each business.
With seven years of proven experience in remote assistance solutions, AMA is helping medical institutions and industrial organizations of all sizes accelerate their digital transformation. Our market-leading XpertEye Assisted Reality platform has been deployed in more than 100 countries, addressing a wide range of applications like remote diagnostics, inspection, scheduling, and workflow management. These unequaled remote interactive collaboration solutions empower our customers to improve productivity, speed up resolution time, and maximize uptime.
AMA is a fast-growing company with offices in Canada, China, France, Germany, Hong Kong, Italy, Japan, Romania, Spain, UK, and the USA - allows us to work in every time zone and reach our customers wherever they are. AMA is listed on Euronext Growth Paris (GB00BNKGZC51 - ALAMA).
More information on www.amaxperteye.com
AMA Media Relations Contact:
Marketing Director AMA
+33 689 182 343